Market research
ALQGC.PA Quantum Genomics Société Anonyme
PA EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 10
- Dividend yield
- Not available
- Beta
- -0.17
Profile
Company facts
- Exchange
- PA
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- FR0011648971
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 10
- Dividend yield
- Not available
- Beta
- -0.17
About
About Quantum Genomics Société Anonyme
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ALQGC.PA discussion.
5 years, 5 months ago
Quantum Genomics Société Anonyme is currently in a long term downtrend where the price is trading 13.8% below its 200 day moving average.
From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 102.2.
Finally, its free cash flow fell by 43.8% to $-3M since the same quarter in the previous year.
Based on the above factors, Quantum Genomics Société Anonyme gets an overall score of 1/5.